Huntington National Bank’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Huntington National Bank’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-300	Closed	–	–	1912
2020 Q1	$0	Hold	300	–	–	﹤0.01%	2007
2019 Q4	$0	Hold	300	–	–	﹤0.01%	2018
2019 Q3	$0	Hold	300	–	–	﹤0.01%	1920
2019 Q2	$0	Hold	300	–	–	﹤0.01%	1950
2019 Q1	$0	Hold	300	–	–	﹤0.01%	1945
2018 Q4	$0	Hold	300	–	–	﹤0.01%	2003
2018 Q3	$0	Hold	300	–	–	﹤0.01%	1996
2018 Q2	$1K	Hold	300	–	–	﹤0.01%	1564
2018 Q1	$1K	Hold	300	–	–	﹤0.01%	1548
2017 Q4	$0	Hold	300	–	–	﹤0.01%	1729
2017 Q3	$2K	Buy	+300	New	+$2.4K	﹤0.01%	1572

Huntington National Bank's NVLN Position: Q2 2020 in Review

Huntington National Bank sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q2 2020, closing a stake of 300 shares.

Huntington National Bank first reported a position in NVLN in Q3 2017 and held it in 11 quarters. The position peaked at $2K in Q3 2017. 0 funds tracked by Wall St. Rank hold NVLN as of Q2 2020.

Huntington National Bank reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q2 2020 after selling out during the quarter.
Huntington National Bank sold 300 Novelion Therapeutics Inc. Common Shares shares in Q2 2020.
Huntington National Bank first reported a position in Novelion Therapeutics Inc. Common Shares in Q3 2017 and held it in 11 quarters.
Huntington National Bank's Novelion Therapeutics Inc. Common Shares position peaked at $2K in Q3 2017.
0 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q2 2020.

Based on Huntington National Bank's 13F filing for Q2 2020, filed 30 Jul 2020.